NCCN Task Force Report: Bone Health in Cancer Care
Authors:
- J. Sybil BiermannJBJ. Sybil Biermann
- Azeez FarookiAFAzeez Farooki
- Monica N. FornierMFMonica N. Fornier
- Robert F. GagelRGRobert F. Gagel
- Rashmi N. KumarRKRashmi N. Kumar
- Charles L. ShapiroCSCharles L. Shapiro
- Andrew ShieldsASAndrew Shields
- Matthew R. SmithMSMatthew R. Smith
- Sandy SrinivasSSSandy Srinivas
- Catherine H. Van PoznakCPCatherine H. Van Poznak
- 1 June 2009
- journal article
- review article
- Published by Harborside Press, LLC in Journal of the National Comprehensive Cancer Network
- Vol. 7 (Suppl_3) , S-1-1
Abstract
Bone health and maintenance of bone integrity are important components of comprehensive cancer care in both early and late stages of disease. Risk factors for osteoporosis are increased in patients with cancer, including women with chemotherapy-induced ovarian failure, those treated with aromatase inhibitors for breast cancer, men receiving androgen-deprivation therapy for prostate cancer, and patients undergoing glucocorticoid therapy. The skeleton is a common site of metastatic cancer recurrence, and skeletal-related events are the cause of significant morbidity. The National Comprehensive Cancer Network (NCCN) convened a multidisciplinary task force on Bone Health in Cancer Care to discuss the progress made in identifying effective screening and therapeutic options for management of treatment-related bone loss; understanding the factors that result in bone metastases; managing skeletal metastases; and evolving strategies to reduce bone recurrences. This report summarizes presentations made at the meeting.Keywords
This publication has 193 references indexed in Scilit:
- Mechanisms of Bone MetastasisNew England Journal of Medicine, 2004
- A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast CancerNew England Journal of Medicine, 2004
- A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast CancerNew England Journal of Medicine, 2003
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancerCancer, 2003
- Randomized, Double-Blind, Controlled Trial of Mitoxantrone/Prednisone and Clodronate Versus Mitoxantrone/Prednisone and Placebo in Patients With Hormone-Refractory Prostate Cancer and PainJournal of Clinical Oncology, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Changes in Bone Mineral Density with Age in Men and Women: A Longitudinal StudyOsteoporosis International, 2002
- Aromatase and Its Inhibitors: Significance for Breast Cancer TherapyRecent Progress in Hormone Research, 2002
- Effect of Calcium and Vitamin D Supplementation on Bone Density in Men and Women 65 Years of Age or OlderNew England Journal of Medicine, 1997
- Risk Factors for Falls among Elderly Persons Living in the CommunityNew England Journal of Medicine, 1988